Načítá se...
Prednisolone for the first rhinovirus‐induced wheezing and 4‐year asthma risk: A randomized trial
BACKGROUND: Previous findings show that corticosteroid treatment during the first acute wheezing episode may reduce recurrent wheezing in children with high rhinovirus genome load at 12‐month follow‐up. Longer‐term effects have not been investigated prospectively. METHODS: After PCR confirmation of...
Uloženo v:
| Vydáno v: | Pediatr Allergy Immunol |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7168117/ https://ncbi.nlm.nih.gov/pubmed/28660720 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/pai.12749 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|